Consensus statement on the management of breakthrough cancer pain: Assessment, treatment and monitoring recommendations

Objective: Breakthrough cancer pain (BTcP) is still underestimated and a percentage of patients are not adequately treated, affecting their quality of life. The aim of this review was to generate a series of expert recommendations based on clinical experience and current scientifi c data on the management of BTcP.